The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller to win FDA approval in more than 20 years.

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine ... oxycodone and fentanyl each year for pain. Nearly 108,000 people died from drug overdoses in 2022, with approximately ...

--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ... approved treatments may require eye injections as often as once ...

By Gina Kolata The Food and Drug Administration approved ... opioids each year for acute pain — from surgery, accidents or trauma — but is nonetheless a large number, he said.

On Thursday, the Food and Drug Administration (FDA ... receive prescriptions for moderate-to-severe acute pain each year. The FDA's approval process for Journavx included an evaluation of its ...

The Food and Drug Administration approved a new medication Thursday ... of the 40 million prescribed opioids each year for acute pain — from surgery, accidents or trauma — but is nonetheless a large ...

US Federal officials have approved a new pain pill by Vertex ... medication. (AP) The drug will be priced at $15.50 per pill, making it significantly more expensive than opioids, which are often ...

“Today’s approval is an important public health milestone in acute pain management,” Jacqueline Corrigan-Curay, acting director of the FDA’s Center for Drug Evaluation and ...

Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...

A Denali Therapeutics drug for the rare enzyme deficiency ... plans to file a biologics license application with the FDA early this year. In Hunter syndrome, genetic mutations lead to deficiency ...

President Donald Trump recently issued two executive orders furthering his policy to reduce the number of federal regulations and the size of ...